Innovations in life sciences, ranging from microbiology to personalized medicine, require close collaborations with a Biobank. During the development of a new innovative health care product, it is critical to gain access to high quality biological resources, including bio-fluids, tissues, prokaryotic and eukaryotic cells, or isolated biomolecules, that are generated in accordance with the latest standards for molecular in vitro examinations.
More than 600 Biobanks are operating in Europe, and it is not an easy task to find the right one that is willing to provide the required samples at a competitive price level. Through our network of academic partners, HALO Research Technology has access to a platform of 100 million biological samples, medical data and associated information, that operate according to the highest standards of ethical and legal compliance, and through transparent and efficient access procedures.
HALO Research Technology can make access available to both population-based and clinical or disease-oriented Biobanks through clearly defined joint development projects. A special service is the preparation of tailor-made materials and assays needed to test pre-analytical factors that might be impacting the analytical performance of in-vitro diagnostics, including companion diagnostics.
